InvestSMART

Integral Diagnostics Limited (ASX: IDX) - Announcements

Current share price for IDX : $1.715 0.005 (0.29%)+

ASX company news and announcements for Integral Diagnostics Limited (IDX) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Integral Diagnostics Limited (IDX) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Integral Diagnostics Limited (IDX), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Integral Diagnostics Limited (IDX)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$641 Notice of change of interests of substantial holder - IDX 10 Aug 2018 11:12AM $2.820 $1.715 fallen by 39.18%
$641 Release from Escrow 9 Aug 2018 9:46AM $2.870 $1.715 fallen by 40.24%
$641 Release from Escrow 26 Jul 2018 1:26PM $2.890 $1.715 fallen by 40.66%
$641 Release from Escrow 17 Jul 2018 5:14PM $2.940 $1.715 fallen by 41.67%
$641 FY18 Financial Results Release Date 6 Jul 2018 12:18PM $3.020 $1.715 fallen by 43.21%
$641 Notice of change of interests of substantial holder - IDX 4 Jul 2018 1:27PM $3.030 $1.715 fallen by 43.40%
$641 Completion of Acquisitions in New Zealand and Victoria 2 Jul 2018 7:29PM n/a $1.715 n/a
$641 Cleansing Statement Section 708A 2 Jul 2018 7:28PM n/a $1.715 n/a
$641 Appendix 3B - Issue of Shares 2 Jul 2018 7:26PM n/a $1.715 n/a
$641 Change in substantial holding from IFL 22 Jun 2018 4:25PM $2.950 $1.715 fallen by 41.86%
$641 Notice of change of interests of substantial holder 19 Jun 2018 11:06AM $2.670 $1.715 fallen by 35.77%
$641 Company Presentation Morgan Stanley Conference 7 Jun 2018 8:36AM $2.950 $1.715 fallen by 41.86%
$641 Reaffirm FY18 Outlook, Acquisition and Release from Escrow 1 Jun 2018 9:58AM $2.790 $1.715 fallen by 38.53%
$641 Acquisition of SRG, Trinity MRI and Cavendish Radiology 29 May 2018 9:53AM $2.610 $1.715 fallen by 34.29%
$641 Ceasing to be a substantial holder 25 May 2018 5:10PM $2.550 $1.715 fallen by 32.75%
$641 Change in substantial holding from IFL 25 May 2018 9:07AM $2.450 $1.715 fallen by 30%
$641 Change of Director's Interest Notice - Chien Ho 4 May 2018 2:47PM $2.560 $1.715 fallen by 33.01%
$641 Change of Director's Interest Notice - Chien Ho 3 May 2018 5:50PM $2.450 $1.715 fallen by 30%
$641 Appendix 3B Issue of Equity Incentive Plan Rights 27 Apr 2018 11:04AM $2.340 $1.715 fallen by 26.71%
$641 Release from Escrow 26 Apr 2018 2:46PM $2.295 $1.715 fallen by 25.27%
$641 Change in substantial holding from IFL 20 Apr 2018 4:17PM $2.370 $1.715 fallen by 27.64%
$641 Notice of change of interests of substantial holder 16 Apr 2018 12:23PM $2.380 $1.715 fallen by 27.94%
$641 Release from Escrow 29 Mar 2018 10:53AM $2.200 $1.715 fallen by 22.05%
$641 CAJ: Lapse of Takeover Offer for Integral Diagnostics 29 Mar 2018 10:03AM $2.250 $1.715 fallen by 23.78%
$641 Ceasing to be a substantial holder 29 Mar 2018 9:38AM $2.220 $1.715 fallen by 22.75%

601 - 625 of 796 results

Page 25 of 32

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.